Solana Company (HSDT)
Solana Company operates in the Asset Management industry of the Financial Services sector, headquartered in Newtown, PA, US. The stock last traded at $2.94, up 1.38% on the session, giving a market capitalisation of $171.7M. On trailing twelve-month figures it carries a trailing P/E of -0.10, a net margin of -1302.8%. Its beta of 1.07 implies it has historically moved more than the broad market.
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
Solana Company is most often compared with the following Financial Services names: